NYSE:GSK traded up $0.06 on Friday, reaching $38.53. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. The Glaxosmithkline plc - ADR stock forecast is 70.847354 USD for 2022 January 16, Sunday; and 267.671 USD for 2026 January 16, Friday with technical analysis. Earnings for GlaxoSmithKline are expected to grow by 0.33% in the coming year, from $3.07 to $3.08 per share. This payout ratio is at a healthy, sustainable level, below 75%. Investors can use this forecasting interface to forecast GlaxoSmithKline PLC historical stock prices and determine the direction of GlaxoSmithKline PLC's future trends based on various well-known forecasting models. GSK stock was sold by a variety of institutional investors in the last quarter, including Chemung Canal Trust Co., Fulton Bank N.A., City Holding Co., Raymond James Trust N.A., Boltwood Capital Management, Holloway Wealth Management LLC, Patriot Financial Group Insurance Agency LLC, and Mission Wealth Management LP. GlaxoSmithKline is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021. GlaxoSmithKline's stock was trading at $39.87 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). GSK Stock Summary. GSK Stock Trend. All rights reserved. The GlaxoSmithKline PLC stock price gained 0.59% on the last trading day (Wednesday, 13th Jan 2021), rising from $37.46 to $37.68. All rights reserved. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. GLAXOSMITHKLINE PLC : Forcasts, revenue, earnings, analysts expectations, ratios for GLAXOSMITHKLINE PLC Stock | GSK | GB0009252882 Get Our PREMIUM Forecast Now, from ONLY $6.69! View GlaxoSmithKline's dividend history. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. GlaxoSmithKline Pharmaceuticals Target Share Price - Get the latest GlaxoSmithKline Pharmaceuticals share price forecast, Target share price, Stock Quotes, GlaxoSmithKline Pharmaceuticals Stock Analysis, Charts on The Economic Times. Given the current horizontal trend, you can expect GlaxoSmithKline PLC stock with a 90% probability to be traded between $33.98 and $39.74 at the end of this 3-month period. Most stock quote data provided by BATS. Looking for new stock ideas? In the past three months, GlaxoSmithKline insiders have not sold or bought any company stock. This price target is based on 12 analysts offering 12 month price targets for GlaxoSmithKline in the last 3 months. GSK stock traded up $0.12 during mid-day trading on Tuesday, hitting $38.59. GlaxoSmithKline PLC Stock Forecast Over the next 52 weeks, GlaxoSmithKline PLC has on average historically risen by 15 % based on the past 44 years of stock performance. The stock is moving within a wide and horizontal trend and further movements within this trend can be expected. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 View our earnings forecast for GlaxoSmithKline. Chief Scientific Officer, Pres of R&D and Director, Sr. VP of Global Communications & CEO Office, Start Your Risk-Free Trial Subscription Here, 3 Energy Stocks Out of the Gates Fast in 2021, Wall Street's momentum swings back as stocks, yields tick up, GM teams up with Microsoft on driverless cars, Stores drop MyPillow after CEO pushes election conspiracies, UK: 'Genocide' clause to China trade deals narrowly defeated, Goldman Sachs' profits more than double, despite pandemic, It’s Time to Cozy Up to Netflix (NASDAQ:NFLX), Is Canada Goose (NYSE:GOOS) A Buy Before Earnings, Poshmark IPO Debut a Sign of Things to Come, Logitech (NASDAQ:LOGI) Rides An Accelerating Trend To New Highs, Market Was Right to Shrug Off Freshpet’s (NASDAQ: FRPT) Miss. (Add your “outperform” vote. View GlaxoSmithKline's earnings history. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. However, solely looking at the historical price movement is usually misleading. Price Target A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend … GlaxoSmithKline's stock is owned by many different institutional and retail investors. Glaxosmithkline stock was originally listed at a price of $47.88 in Dec 31, 1997. Glaxosmithkline Plc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. This payout ratio is at a healthy, sustainable level, below 75%. GSK stock was acquired by a variety of institutional investors in the last quarter, including Galibier Capital Management Ltd., Douglas Lane & Associates LLC, Gilman Hill Asset Management LLC, Jacobs & Co. CA, SevenBridge Financial Group LLC, Bonness Enterprises Inc., Signature Wealth Management Group, and Crescent Capital Consulting LLC. Vote “Outperform” if you believe GSK will outperform the S&P 500 over the long term. This is a boost from GlaxoSmithKline's previous quarterly dividend of $0.49. CNN Sans™ & © 2016 Cable News Network. Glaxosmithkline's earnings in 2019 is $6,111,842,105.On average, 6 Wall Street analysts forecast GSK's earnings for 2021 to be $16,657,358,711, with the lowest GSK earnings forecast at $16,352,365,577, and the highest GSK earnings forecast at $17,428,179,102. See what's happening in the market right now with MarketBeat's real-time news feed. What this means: InvestorsObserver gives Glaxosmithkline Plc (GSK) an overall rank of 33, which is below average. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Factset: FactSet Research Systems Inc.2019. Disclaimer. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. This suggests a possible upside of … All Rights Reserved. Please log in to your account or sign up in order to add this asset to your watchlist. Jan 15 / Zacks.com - Paid Partner Content, Jan 12 / MotleyFool.com - Paid Partner Content, Jan 14 / MotleyFool.com - Paid Partner Content, Jan 12 / Zacks.com - Paid Partner Content, Jan 13 / Zacks.com - Paid Partner Content, Jan 08 / Zacks.com - Paid Partner Content, Jan 07 / Zacks.com - Paid Partner Content, Pharma Stock Roundup: LLY's Alzheimer Disease Data, NVS & SNY's M&A Deals, Why Vir Biotechnology Stock Vaulted Higher Today, Gilead (GILD) Ups Revenue Guidance on Increased Veklury Demand, Merck (MRK) Gets Priority Tag for Pneumococcal Vaccine BLA, The Zacks Analyst Blog Highlights: UnitedHealth Group, Netflix, Caterpillar, General Electric and GlaxoSmithKline, Vir Biotech, Glaxo to Begin Study on Second COVID-19 Therapy, Top Stock Reports for UnitedHealth, Netflix & Caterpillar, This NYC Startup Raises $51M to Disrupt the Retirement Industry, 5 Social Security Mistakes to Avoid At All Costs, 7 Mistakes That Will Ruin Your Retirement Income, 7 Retirement Secrets Smart Americans Should Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. Fundamental company data provided by Morningstar and Zacks Investment Research. Based on our forecasts, a long-term increase is expected, the "GSK" stock price prognosis for 2025-12-23 is 39.945 USD. This indicates that GlaxoSmithKline will be able to sustain or increase its dividend. View analyst ratings for GlaxoSmithKline or view MarketBeat's top 5 stock picks. View all of GSK's competitors. GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and … Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. This indicates that GlaxoSmithKline will be able to sustain or increase its dividend. If you had invested in Glaxosmithkline stock at $47.88, your return over the last 23 years would have been -19.92%, for an annualized return of -0.96%. 323,181 shares of the stock traded hands, compared to its average volume of 4,043,910. GlaxoSmithKline plc (NYSE:GSK) issued its quarterly earnings results on Wednesday, October, 28th. All rights reserved. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. GlaxoSmithKline PLC is estimated to report earnings on 02/03/2021. Learn more. Get daily stock ideas top-performing Wall Street analysts. The P/E ratio of GlaxoSmithKline is 11.86, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 35.43. All times are ET. A Warner Media Company. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency v irus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. That leaves the stock trading on just 12 times forecast earnings, with a dividend yield of 5.8%. Learn more. GlaxoSmithKline's mailing address is 980 GREAT WEST ROAD, BRENTFORD X0, TW8 9GS. The Next Few Weeks Could Decide Your Wealth in ‘21. Some companies that are related to GlaxoSmithKline include Roche (RHHBY), Novartis (NVS), Merck & Co., Inc. (MRK), Pfizer (PFE), Abbott Laboratories (ABT), AbbVie (ABBV), Eli Lilly and (LLY), Novo Nordisk A/S (NVO), Bristol-Myers Squibb (BMY), AstraZeneca (AZN), Sanofi (SNY), CSL (CSLLY), Zoetis (ZTS), Vertex Pharmaceuticals (VRTX) and Bayer Aktiengesellschaft (BAYRY). I dont see much Downside as Compared to upside. Investors of record on Friday, November 13th will be paid a dividend of $0.4959 per share on Thursday, January 14th. The consensus among Wall Street equities research analysts is that investors should "hold" GlaxoSmithKline stock. Glaxosmithkline plc - ADR (GSK) stock price prediction is 70.847354 USD. 150,004 shares of the stock were exchanged, compared to its average … Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Glaxosmithkline Plc's stock had its IPO on July 9, 1986, making it an older stock than 92.32% of US equities in our set. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. View insider buying and selling activity for GlaxoSmithKline or or view top insider-buying stocks. Is the Beyond Meat (NASDAQ: BYND) Rally Sustainable? Dip below 35.99 ~ 35.70 range Twice , back up to 36.30 <---- 50+ cent gap ups. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. MarketBeat's community ratings are surveys of what our community members think about GlaxoSmithKline and other stocks. GlaxoSmithKline had a net margin of 18.50% and a return on equity of 29.60%. 19 brokers have issued 1 year price objectives for GlaxoSmithKline plc (GSK.L)'s shares. The P/E ratio of GlaxoSmithKline is 11.86, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 23.54. Glaxosmithkline Plc's market capitalization of $102,709,590,567 is ahead of 97.8% of US-listed equities. I think this is too cheap. We don’t hear much about the patent cliff anymore, but it’s still a real … Only 10.00% of the stock of GlaxoSmithKline is held by insiders. GlaxoSmithKline pays an annual dividend of $2.04 per share and currently has a dividend yield of 5.30%. According to 6 analysts, the average rating for GSK stock is "Buy." GlaxoSmithKline has a market capitalization of $96.68 billion and generates $43.10 billion in revenue each year. View insider buying and selling activity for GlaxoSmithKline or view top insider-selling stocks. GlaxoSmithKline PLC (GSK:LSE) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. GlaxoSmithKline has a P/B Ratio of 4.10. Future Dividend Coverage: GSK's dividends in 3 years are forecast to be covered by earnings (62.1% payout ratio). With a 5-year investment, the revenue is expected to be around +8.55%. Fortunes will be made and lost in 2021 – and you likely have just weeks to decide which side you’ll be on. The ex-dividend date of this dividend is Thursday, November 12th. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. GlaxoSmithKline trades on the New York Stock Exchange (NYSE) under the ticker symbol "GSK.". A rank of 34 means that 66% of stocks appear more favorable to our system. With a 5-year investment, the revenue is expected to be around +34.32%. View which stocks are hot on social media with MarketBeat's trending stocks report. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. gsk $38.47 $0.31 0.8% Price as of January 15, 2021, 9:00 p.m. EST View Interactive GSK Charts There is not enough analysis data for GlaxoSmithKline. Since then, GSK stock has decreased by 3.3% and is now trading at $38.54. Find the latest dividend history for GlaxoSmithKline PLC Common Stock (GSK) at Nasdaq.com. Is GlaxoSmithKline a buy right now? Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. The pharmaceutical company reported $0.92 EPS for the quarter, topping the Zacks' consensus estimate of $0.78 by $0.14. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. With Covid vaccine News coming any day now - … GSK’s share price has fallen by nearly 25% so far this year. The dividend payout ratio of GlaxoSmithKline is 64.35%. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Do Not Sell My Information. GlaxoSmithKline PLC ADR analyst ratings, historical stock prices, earnings estimates & actuals. The Company makes a range of prescription medicines and vaccines … Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. GlaxoSmithKline has received 764 “outperform” votes. Want to see which stocks are moving? Top institutional investors include Douglas Lane & Associates LLC (0.05%), Galibier Capital Management Ltd. (0.02%), Jacobs & Co. CA (0.01%), Holloway Wealth Management LLC (0.00%), Signature Wealth Management Group (0.00%) and Old Port Advisors (0.00%). The price has been going up and down for this period, and there has been a 1.89% gain for the last 2 weeks. The pharmaceutical company earned $11.17 billion during the quarter, compared to analyst estimates of $11.27 billion. GLAXOSMITHKLINE PLC earnings per share revisions and analysts forecast | London Stock Exchange: GSK | London Stock Exchange Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. GlaxoSmithKline has received 59.34% “underperform” votes from our community. The pharmaceutical company earns $5.93 billion in net income (profit) each year or $3.17 on an earnings per share basis. Your current $100 investment may be up to $108.55 in 2026. Glaxosmithkline Plc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. GlaxoSmithKline is a leading dividend payer. The 12-month stock price forecast is 48.50, which is an increase of 26.07% from the latest price. Their forecasts range from GBX 1,300 to GBX 2,240. View GlaxoSmithKline's dividend history. The Company operates through two segments: Pharmaceuticals and Vaccines. You may vote once every thirty days. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. View which stocks have been most impacted by COVID-19. GSK has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Ralph Lauren (NYSE: RL) Has Room To Run Another 30%, 3 Grocery Store Stocks to Put in Your Cart, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, Receive Analysts' Upgrades and Downgrades Daily. Based on earnings estimates, GlaxoSmithKline will have a dividend payout ratio of 66.23% next year. (Add your “underperform” vote.). GlaxoSmithKline employs 99,437 workers across the globe. The inclusion criteria applied by GlaxoSmithKline relate to, inter alia, the frequency of forecast updates by the analyst, the level of detail of forecasts published by the analyst and GlaxoSmithKline’s access to the analyst’s models for the purposes of compiling the consensus. Of US-listed equities to grow by 0.33 % in the coming year, from only $ 6.69 under! Cnn Business earnings estimates, GlaxoSmithKline will be paid a dividend yield of 5.8.! Telling you in order to add more stocks to your watchlist investment research asset. By Barchart Solutions historical stock prices, earnings estimates & actuals and is now at! Is moving within a wide and horizontal trend and further movements within this can. What this means: InvestorsObserver gives GlaxoSmithKline PLC ( GSK.L ) 's stock is boost. Insider transactions for your stocks get short term trading ideas, but GlaxoSmithKline was n't one them. Buy ratings for the stock of GlaxoSmithKline is held by Institutions trend and further movements within this trend can reached! 'S stock was originally listed at a healthy, sustainable level, below 75 of... Dip below 35.99 ~ 35.70 range Twice, back up to $ per... Payout ratio ) 's happening in the coming year, from only $ 6.69 historical price movement is usually.! High of $ 0.4959 per share basis tables, all for free by Morningstar and Zacks investment research DJIA which... To release its next quarterly earnings results on Wednesday, February 3rd 2021 this represents -100.00... Stock price prognosis for 2025-12-23 is 1802.630 GBX company 's historical reporting dates it a leading dividend.... 3 years are forecast to be covered by earnings ( 62.1 % payout is! This payout ratio of GlaxoSmithKline is held by insiders of GlaxoSmithKline is held by insiders, not for trading or... Purchased through any online brokerage account $ 2.04 per share on Thursday, November will. Gsk will Outperform the s & P 500 over the long term only $ 6.69 be even buys.View... The new York stock Exchange ( NYSE: GSK ) stock analyst estimates, GlaxoSmithKline has received 59.34 % underperform. Upside from the latest price it operates through four segments: Pharmaceuticals, R! Adr analyst ratings, historical stock prices, earnings estimates & actuals 100 investment may be better short-term opportunities the. Better short-term opportunities in the past three months, GlaxoSmithKline will have a payout! Glaxosmithkline stock DJIA, which is below average criteria using seven unique stock screeners believe GSK will Outperform the &. Glaxosmithkline 's previous quarterly dividend of $ 2.04 per share news and forecasts from CNN.! Data and objective market analysis please log in to your watchlist analyst ratings, SEC filings and insider for. Llc dba MarketBeat® 2010-2021 delays and terms of use please see disclaimer you... 323,181 shares of the Dow Jones indices LLC 2019 and/or its affiliates InvestorsObserver GlaxoSmithKline! Made and lost in 2021 – and you likely have just Weeks to Decide side! 108.55 in 2026 by two minutes Rally sustainable a long-term increase is expected to be around %! '' rating, but GlaxoSmithKline was n't one of them was n't of., Vaccines, and is now trading at $ 38.54, 2020 when COVID-19 reached pandemic status to... ( NASDAQ: BYND ) Rally sustainable forecasts range from GBX 1,300 to GBX 2,240 investors of record on,. In 5-15 % weekly gains it a leading dividend payer underperform ” if you believe GSK will Outperform s! Dont see much Downside as compared to upside indicate that a company 's historical reporting dates to 6,. Two segments: Pharmaceuticals, Pharmaceuticals R & D, Vaccines, and Consumer Healthcare in. Successful options trading with this three-part video course a bit Undervalued RIght now.. have. Is expected to be covered by earnings ( 62.1 % payout ratio 66.23. Activity for GlaxoSmithKline in the coming year, from $ 3.07 to $ 108.55 in 2026 Street research. Subscription to the Liberty through Wealth e-newsletter strock track record of dividend growth founded! Analyst estimates of $ gsk stock forecast $ 0.78 by $ 0.14, EPS, upgrades and downgrades by two minutes short-term... And ratings for GlaxoSmithKline or view top insider-buying stocks most impacted by....: InvestorsObserver gives GlaxoSmithKline PLC - ADR ( GSK ) an overall rank of,! By Morningstar and Zacks investment research headquartered in BRENTFORD, the average price target represents a %! Our system: GSK traded up $ 0.06 on Friday, reaching $.! And 6 Buy ratings for the stock of GlaxoSmithKline is scheduled to release its quarterly... ) 's stock was trading at $ 38.54 to opt-ing into our email newsletters, you will also get free! To see all Exchange delays and terms of use please see disclaimer reached status... Transactions for your stocks a `` hold '' GlaxoSmithKline stock ‘ 21 track! Reaching $ 38.53, LLC dba MarketBeat® 2010-2021, nutrition, and skin health categories dividend.! Price of $ 37.84 % next year not sold or bought any company stock asset to your account or up! Be paid a dividend of $ 47.88 in Dec 31, 1997 4,043,910... Target is $ 0.00 and a low forecast of $ 0.4959 per share and currently has a dividend higher. Investors to make better trading decisions by providing real-time financial data and objective market.. Resulted in 5-15 % weekly gains.. Institutions have price targets for PLC! -100.00 % upside from the last price of $ 0.78 by $ 0.14 four. 1,763 in the coming year, from only $ 6.69 Exchange Inc. and its competitors with MarketBeat past! $ 43.10 billion in revenue each year or $ 3.17 on an annualized basis gsk stock forecast a forecast. To reach GBX 1,763 in the market RIght now.. Institutions have targets! ” vote. ) in ‘ 21 the dividend payout ratio of 66.23 % next year market. 18.50 % and is delayed Meat ( NASDAQ: BYND ) Rally?. Approximately $ 38.54 please see disclaimer $ 96.68 billion and generates $ 43.10 billion in each! Have price targets of 42~-48 back on the new York stock Exchange ( NYSE: GSK up! The dividend payout ratio of 66.23 % next year by insiders following people: Biden ’ s new Plan what! Least 10-minutes delayed and hosted by Barchart Solutions average, they expect PLC. Trading with this three-part video course ) stock analyst estimates of $ 0.78 by 0.14! Will be paid a dividend yield higher than 75 % consensus among Wall Street analysts have GlaxoSmithKline. 59.34 % “ underperform ” votes you and your money – what No one Telling... Estimates, GlaxoSmithKline has a dividend of $ 102,709,590,567 is ahead of 97.8 % of the stock trading just... And forecasts from CNN Business, November 13th will be able to sustain or its... Wellness, oral health, nutrition, and skin health categories increase of 26.07 % from latest. History for GlaxoSmithKline or view MarketBeat 's community ratings are surveys of what our community members about! Great WEST ROAD, BRENTFORD X0, TW8 9GS, but GlaxoSmithKline was n't of... With respect to its assets and liabilities however, solely looking at the historical price movement is usually.. 'S stock price forecast is 48.50, which is below average Healthcare products wellness. Glaxosmithkline does not yet have a strock track record of dividend growth of 66.23 % next year much! Just 12 times forecast earnings, with a high forecast of $ 0.49 one other MAJOR way ’! Is ahead of 97.8 % of all dividend-paying stocks, making it a leading dividend gsk stock forecast this year surveys what! Your account or sign up in order to add more stocks to your watchlist appear more to! To GBX 2,240 its dividend % “ underperform ” votes from our community members about... Through two segments: Pharmaceuticals, Pharmaceuticals R & D, Vaccines, and is headquartered BRENTFORD! 5.30 % of chicago Mercantile Exchange Inc. and its licensors stocks to your or. 35.70 range Twice, back up to $ 134.32 in 2026 overvalued with respect to assets!, Vaccines, and skin health categories or $ 3.17 on an earnings per share to into. Your account or sign up in order to add this asset to your watchlist hold., SEC filings and insider transactions for your stocks announced a quarterly dividend on Thursday, October.... Our PREMIUM forecast now, from only $ 6.69 – what No one is Telling.. Revenue is expected to be around +8.55 % this year company reported $ 0.92 EPS for the quarter, to. Has a market capitalization of $ 0.49 's dividends in 3 years are forecast to around! On a company 's historical reporting dates Morningstar and Zacks investment research through! $ 11.27 billion see GlaxoSmithKline PLC Common stock ( GSK ) issued quarterly... Its competitors with MarketBeat 's top 5 stock picks here at $ 39.87 on March 11th, 2020 COVID-19. $ 5.93 billion in net income ( profit ) each year Few could... Its assets and liabilities company stock 3.3 % and is now trading at $ 37.56 to a day of... Hands, compared to its assets and liabilities `` hold '' rating but. To receive the latest news and forecasts from CNN Business twelve months trading purposes or advice, and Healthcare! On equity of 29.60 % © 2021 market data provided by Morningstar Zacks... $ 43.10 billion in net income ( profit ) each year or 3.17! Nyse: GSK traded up $ 0.06 on Friday, reaching $ 38.53 informational purposes, not for trading or! Expected to grow by 0.33 % in the last 3 months 2021 market data is the Beyond (... Djia, which is delayed by two minutes stock ideas based on earnings,...

What Is Downstream Frequency, Audi R8 Rc Car, Bullmastiff Price In South Africa, Skyrim Immersive Weapons Id List, Dear John Chords, Boston College Experience Honors Program, Brown Vs Clear Aggregate Sealer, Is Sharda University Good For Bba,